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Interaction of the NK Cell Inhibitory Receptor
Ly49A with H-2Dd: Identification of a Site
Distinct from the TCR Site
heterodimers CD94/NKG2, as well as disulfide-linked
homodimers such as Ly49A, NKR-P1, and CD69). A
common feature of the inhibitory receptors of these two
structural families is the presence of a cytoplasmic im-
munoreceptor tyrosine-based inhibition motif (ITIM) that
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Figure 1. Construction and Expression of
Soluble Ly49A Fragments
(A) The indicated regions of the C57BL/6
Ly49A cDNA were amplified and cloned as
described in the Experimental Procedures.
The expected molecular mass of the encoded
monomer is listed.
(B) Following expression as inclusion bodies,
solubilization, refolding, and purification as
described in the Experimental Procedures,
Ly49A EC was examined by size exclusion
chromatography on a Superdex 75 column.
The recovered peak was also examined in
SDS-PAGE under reducing (R) and nonreduc-
ing (NR) conditions as shown in the inset.
about the interaction of NK cell inhibitory receptors of the same MHC/peptide complex can simultaneously in-
teract with both TCR and NK receptors. Finally, a quanti-the C-type lectin family with MHC I/peptide complexes
remain. The requirements for carbohydrate moieties on tative analysis of both the kinetics and equilibrium bind-
ing interactions of an NK receptor with MHC I/peptidethe MHC I ligand and the role of Ca21 in such binding
are controversial. Although Ly49 proteins belong to the ligands would allow direct measurement of the effects of
different peptides and MHC molecules on the interactionfamily of C-type lectins, they lack the specific amino
acids critical for Ca21 and sugar binding found in bona and would permit comparison with other cell surface
immune cell receptors that have already been studied.fide C-type lectins (Drickamer, 1993; Weis et al., 1998).
The precise site of interaction of the inhibitory receptor In an effort to clarify the details of the binding interac-
tions of the Ly49 family, we have engineered the extra-with the MHC molecule remains unclear despite several
mutagenic studies (Matsumoto et al., 1998; Sundback cellular lectin-like region of Ly49A for expression in
Escherichia coli and have used this in in vitro bindinget al., 1998; Waldenstrom et al., 1998; Lian et al., 1999).
This ambiguity may result from the inherent complexity assays employing bacterially expressed and refolded
MHC I/peptide complexes as well as in ex vivo analysesof functional assays using a biological readout. We
would expect that a system that specifically examines using viable lymphoid cells.
the binary interactions of a single NK receptor and a
single MHC/peptide complex would permit resolution Results and Discussion
of these discrepancies.
Although the prevailing view of NK cell inhibitory re- To produce soluble, functional Ly49A proteins, cDNA
constructs encoding different extracellular regions ofceptors is that their primary function is to modulate the
activity of NK cells, a growing body of evidence suggests the C57BL/6 allelic form of Ly49A were cloned in a bacte-
rial expression vector (Figure 1). The C-type lectin-likethat inhibitory receptors of both the IgSf and C-type
lectin families may play a role in controlling the activation NK receptor domain (NKD) is contained in three of the
four fragments generated. The full extracellular region,of those T cells that express these receptors (Moretta
et al., 1984; Roland and Cazenave, 1992; Ciccone et al., designated Ly49A EC, which includes the stalk and the
NKD, two truncated fragments known as Ly49A NKD-L1996; Mandelboim et al., 1996; Sugie et al., 1996; Vali-
ante and Parham, 1996; Bendelac et al., 1997; MacDon- (long) and NKD-S (short), and the stalk region alone
(Ly49A stalk), were expressed, refolded, and purifiedald et al., 1998). Thus, it is important to know whether
NK Inhibitory Receptor/MHC I Binding Interactions
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Figure 2. Anti-Ly49A Monoclonal Antibodies
Specifically Bind to Ly49A EC and Ly49A
NKD-L
Purified preparations of the three indicated
molecules were immobilized to a CM-5 chip
and analyzed for binding to the indicated
mAbs by SPR using the BIACore 2000 as de-
scribed in the Experimental Procedures. So-
lution phase analytes (mAbs) were injected at
t 5 83 s. Dissociation washout was initiated
at t 5 365 s. To evaluate the potential for
deterioration of the coupled surfaces with
successive cycles of binding and regenera-
tion, mAb A1 was used in the first (solid circle)
and last (open square) runs.
(see the Experimental Procedures). Test ligands for did not interact (Figure 3C, dotted line). However, the
data are readily described by a mathematical model thatthese molecules, H-2Dd and H-2Kb, expressed in bacte-
includes terms for an interaction between H-2Dd andria and refolded in vitro, were prepared as described
Ly49A EC, with an equilibrium constant, KD, of 0.75 3previously (Li et al., 1998). Size exclusion chromatogra-
1026 M. Thus, the centrifugation experiments indicatephy suggested that Ly49A EC (Figure 1B) and Ly49A
that the H-2Dd complex is monomeric, the Ly49A ECNKD-L (data not shown) were noncovalent dimers, since
molecule has a tendency to form noncovalent dimersthe peak had a column retention time less than expected
at moderate concentration, and the Ly49A EC and H-2Ddfor molecules of the predicted molecular weight and
interact with an affinity of about 1 mM at 48C in solution.was asymmetric (Figure 1B). SDS-PAGE indicated that
(Technical limitations of AUC for the given molecules inLy49A EC (Figure 1B, inset) and Ly49A NKD-L (data
the available concentration range prevent discrimina-not shown) behaved as monomers containing intrachain
tion of the stoichiometry of binding [Laue and Stafford,disulfide bonds, since the homogeneous band migrated
1999].)more slowly under reducing conditions. Ly49A NKD-S,
Since the MHC molecules are produced in a bacterialhowever, was a disulfide-bonded homodimer (data not
expression system, no N-linked glycans are present.shown). We tested the binding of these engineered frag-
Both Ly49 and MHC molecules were prepared and ana-ments to a panel of monoclonal antibodies with known
lyzed in buffers free of Ca21. Binding under these condi-specificity (Figure 2). As shown, the correct mAbs bound
tions indicates the lack of a Ca21 requirement and isto the recombinant refolded Ly49A proteins Ly49A EC and
consistent with amino acid sequence comparisons thatNKD-L very well (Figure 2). In contrast, Ly49A NKD-S,
indicate that Ly49A lacks the Ca21 binding motif of truewhich begins with amino acid 149 of the Ly49A chain,
C-type lectins and also lacks the amino acids criticaland the stalk alone (data not shown), which extends
for sugar binding (Drickamer, 1993; Weis et al., 1998).from amino acid 67 to 148, failed to bind to any of the
Therefore, neither carbohydrate nor Ca21 are requiredantibodies. In addition, 4D11 antibody against Ly49G2
for the interaction of H-2Dd with Ly49A EC.bound both Ly49A EC and Ly49A NKD-L at a low level.
To explore further the nature of the interaction be-The SW5E6 mAb, specific for Ly49C/I, showed no de-
tween H-2Dd and Ly49A, we examined binding by sur-
tectable binding to either Ly49A EC or Ly49A NKD-L.
face plasmon resonance (SPR). Ly49A EC, Ly49A NKD-L,
These experiments map the epitopes for A1, YE1±32,
and Ly49A NKD-S were each covalently coupled to a
YE1±48, and JR9.318 to the NKD-L fragment. The low biosensor surface, and binding of H-2Dd complexed with
level of binding of 4D11 to Ly49A EC and Ly49A NKD-L P18-I10 or with a motif peptide was measured (Figures
is consistent with previous results (Takei et al., 1997). 4A±4F). Both H-2Dd/P18-I10 and H-2Dd/motif peptide
To evaluate the interaction of Ly49A EC with purified complexes bound the immobilized Ly49A EC and Ly49A
complexes of H-2Dd/P18-I10, we first used equilibrium NKD-L well. Ly49A NKD-S bound very weakly, if at all,
analytical ultracentrifugation (AUC) (Figure 3). The con- to both H-2Dd preparations.
centration distribution at equilibrium under three differ- Curve fitting of data from these and other experiments
ent conditions of rotor speed and initial concentration provided values for binding parameters as given in Table
allows curve fitting to a monomeric, noninteracting 1. (These calculations are based on a model in which
model for the H-2Dd/P18-I10 complex (Figure 3A). How- monomeric H-2Dd/peptide complexes bind monova-
ever, Ly49A EC (Figure 3B) requires a simple monomer/ lently to the coupled Ly49A receptors.) A number of
dimer association model to account for the concentra- independent preparations of Ly49A EC were examined
tion distribution that differs from that predicted by a for their ability to bind H-2Dd refolded with several differ-
simple monomer model. These data are consistent with a ent peptides. For each of these experiments, the KD
monomer/dimer equilibrium constant, KD, of 7.1 3 1026 M. determined for the Ly49A/H-2Dd interactions was re-
To examine the potential for interaction of H-2Dd/ markably similar, irrespective of the particular pep-
P18-I10 with Ly49A EC, the two molecules were mixed tide complexed with the MHC. To evaluate the peptide
in the ultracentrifuge cell, and the concentration distri- specificity of Ly49A EC, we compared several dif-
bution at equilibrium was compared to that of each of ferent peptide/H-2Dd complexes: H-2Dd assembled with
the two molecules examined alone. This concentration either P18-I10 peptide, a P18-I10 variant peptide N8
distribution profile is distinct from the best-fit profile (RGPGRAFNTI) known not to interact with an H-2Dd-
restricted P18-I10-specific T cell receptor (Plaksin et al.,possible under the assumption that the two components
Immunity
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Figure 3. AUC Analysis of Ly49A EC, and Its Interaction with H-2Dd/P18-I10
Experiments and data analysis were carried out as described in the Experimental Procedures.
(A) Sedimentation equilibrium distributions of H-2Dd/P18-I10 complexes, scanned at 280 nm. Data from two independent experiments are
shown, one at a rotor speed of 16,000 rpm (O) and one in sequential sedimentation equilibria at 16,000 rpm (D) and 24,000 rpm (1), respectively.
The solid line is the global curve fit for a single, noninteracting species of the molar mass as predicted from the amino acid composition.
Residuals of the difference between the data points and the curve fits are shown in the inset below.
(B) Ly49A EC at loading concentrations of 8.3 and 5 mM, scanned at a wavelength of 280 nm, in sedimentation equilibrium at rotor speeds
of 16,000 rpm (1) and 21,000 rpm (D), respectively, and with a loading concentration of 0.7 mM, scanned at 230 nm, at a rotor speed of 25,000
rpm (O). The solid lines are the best-fit result from a global analysis of 13 data sets based on a monomer-dimer self-association model,
resulting in a dimerization constant of 7.1 3 1026 M (range 3.7 3 1026 M to 1.7 3 1025 M). Residuals are shown in the lower panel.
(C) Sedimentation equilibrium distribution of Ly49A EC (5.9 mM) and H-2Dd/P18-I10 (1.7 mM), scanned at 280 nm, at rotor speeds of 16,000
rpm (1), 20,000 rpm (x), and 24,000 rpm (D), respectively. Solid lines are global best-fit distributions of a model with free H-2Dd/P18-I10, Ly49A
EC in a monomer-dimer equilibrium, and mixed complexes of Ly49A EC binding to H-2Dd/P18-I10 with a microscopic binding constant, KD,
of 750 nM, independent of the oligomeric state of Ly49A EC. Virtually identical fits can be achieved for all binding constants, KD , 1 mM, and
for interaction models assuming exclusively the Ly49A EC monomer or dimer, respectively, to represent the H-2Dd/P18-I10 binding site.
Residuals are shown in the lower panel. For comparison, the best-fit distribution for the same model without Ly49A EC H-2Dd/P18-I10
interaction is shown by dotted lines, with the corresponding residuals in the middle panel.
1997), or with an H-2Dd motif peptide (AGPARAAAL) lack of peptide specificity with respect to the interaction
of H-2Dd/peptide complexes with Ly49A EC contrasts(Figures 4G±4I). All bind the solid phase Ly49 EC well.
To test the MHC I specificity, H-2Kb/VSV complexes sharply with the exquisite specificity of binding by the
H-2Dd/P18-I10-restricted scTCR (Figure 4K). In additionwere used; they bound Ly49A EC poorly (Figure 4J). The
Figure 4. Binding of MHC/Peptide Complexes
to Ly49A
CM-5 biosensor chips were coupled with
Ly49A EC (A, D, and G±J), Ly49A NKD-L (B
and E), Ly49A NKD-S (C and F), or the clono-
typic scTCR (K) by standard procedures and
were then exposed to either H-2Dd/P18-I10
(A±C, G, and K), H-2Dd/motif (D±F and I),
H-2Dd/P18N8 (H), or H-2Kb/VSV (J) complexes
as solution phase analytes. The injection of
analyte commenced at t 5 83 s. Washout was
initiated at t 5 365 sec. Curves shown have
had background values subtracted.
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Table 1. Binding Parameters of NK Receptor/MHC I Interactions as Measured by SPR
Experiment Ligand Analyte ka (M21s21) kd (s21) t1¤2 (s) KD (mM) Reference
1 Ly49A EC1 DdP18I10 1300 0.034 20 26 This study
Ly49A EC2 DdP18I10 1600 0.028 25 18 This study
Ly49A EC1 DdN8 3300 0.025 28 7.6 This study
Ly49A EC2 DdN8 2700 0.025 28 9.4 This study
Ly49A EC1 Ddmotif 5200 0.039 18 13 This study
Ly49A EC2 Ddmotif 3600 0.035 20 9.3 This study
2 Ly49A EC3 DdP18I10 5100 0.031 22 6.1 This study
Ly49A EC3 DdN8 1600 0.031 22 20 This study
Ly49A EC3 Ddmotif 2000 0.024 29 12 This study
3 Ly49A EC1 Dd motif 2400 0.024 29 10 This study
Ly49A NKD-L Dd motif 2500 0.021 33 8.4 This study
Previous studies scTCR DdP18I10 29300 0.179 3.9 6.1 (Plaksin et al., 1997)
NKAT1 HLA-Cw6 4 .2.6 ,0.27 11.2 (ValeÂ s-GoÂ mez et al., 1998a;
ValeÂ s-GoÂ mez et al., 1998b)
NKAT2 HLA-Cw7 4 .1.5 ,0.46 9.1 (ValeÂ s-GoÂ mez et al., 1998a;
ValeÂ s-GoÂ mez et al., 1998b)
CD94/NKG2A HLA-E 4 0.42±1.33 2.3 to $75.3 2.1 to . 56.65 (ValeÂ s-GoÂ mez et al., 1999)
CD94/NKG2C HLA-E 4 1.80 10.8 to $238 11.9 to .107 (ValeÂ s-GoÂ mez et al., 1999)
Data were obtained from binding progress curves fit using BIAEval 3.0 as described in detail in the Experimental Procedures. t1¤2 values were
calculated from the kd values by the relationship t1¤2 5 In 2/kd.
Three different preparations of Ly49A EC were used.
1 This preparation was refolded, purified, and repurified on an A1 immunoadsorbent column.
2 This preparation was refolded, purified, and repurified on a YE1-32 immunoadsorbent column.
3 This preparation was refolded, purified, and repurified on the A1 column and further purified by ion exchange chromatography.
4 As reported, the authors were unable to measure ka values for three interactions due to their high rate.
5 These experiments revealed peptide-specific binding parameters.
to confirming the H-2Dd specificity of Ly49A EC binding, but might be ineffective in binding normal cell surface
H-2Dd. We used chemically biotinylated Ly49A EC tothese SPR data establish, using a number of different
preparations of carbohydrate-free MHC/peptide com- stain living splenocytes from several representative in-
bred mouse strains (Figure 5). As shown, the biotinylatedplexes, that carbohydrate is not necessary for the inter-
action of Ly49A EC with H-2Dd. The values obtained for Ly49A EC stains BALB/c (H-2Dd1) splenocytes well (Fig-
ure 5A). In addition, C3H (H-2k) splenocytes are stainedthe kinetic association rate constants are between 1300
and 5200 M21s21, which indicate a relatively slow associ- at a level higher than those of C57BL/6. This is consistent
with functional experiments that indicate that H-2Dk isation process, particularly in contrast to the association
rates of MHC/TCR interactions, which are often at least a physiological ligand for Ly49A (Karlhofer et al., 1994).
To evaluate the specificity of the staining of C57BL/6, we104. The dissociation rate constants are indicative of
moderately rapid t1/2 and reveal a stability that approxi- compared BALB/c, C57BL/6, and b2m2/2 cells (Figures
5B±5D). In this experiment, the staining was competedmates that of the most stable MHC/TCR interactions
(Corr et al., 1994). It is remarkable that the measured KD with nonbiotinylated Ly49A EC. As shown, reactivity with
BALB/c cells was significantly reduced by exposure tovalues fall into the same range (6.1 to 26 mM) as KD
measured for most TCR binding to MHC molecules (Fre- the unlabeled Ly49A EC, while the binding to C57BL/6
was unaffected. In addition, the level of staining of themont et al., 1996; Davis et al., 1998). This may reflect a
similar cell surface density of the component molecules, b2m2/2 cells was lower. We conclude that biotinylated
Ly49A EC specifically binds cell surface molecules ona similar need for multivalency in order to achieve a
dwell time adequate for signaling, and a similar efficacy BALB/c splenocytes but does not specifically bind mole-
cules expressed on either C57BL/6 or b2m2/2. Theseof the intracellular signaling events employed by both
classes of receptor. In contrast to the parameters ob- results indicate that natural ligands for Ly49A as ex-
pressed on the surface of living cells can interact withtained for the binding of the human HLA-Cw6 and HLA-
Cw7 molecules to NK receptors of the IgSf, NKAT1, and the bacterially expressed recombinant molecule. We
have recently described the use of this biotinylatedNKAT2, which show extremely rapid kinetic association
rates and relatively rapid kinetic dissociation rates Ly49A in recognizing H-2Dd on cells of the D8 transgenic
mouse, which expresses H-2Dd on a C57BL/6 back-(ValeÂ s-GoÂ mez et al., 1998a, 1998b), our measurements
indicate that the Ly49A NK receptor follows kinetic pa- ground (Chung et al., 1999).
Since Ly49A recognizes H-2Dd in a peptide-depen-rameters similar to those of T cell receptors. Recently,
the peptide-dependent nature of the interaction of dent but not peptide-specific fashion, while clonally ex-
pressed TCRab directed against H-2Dd-restricted pep-HLA-E with the CD94/NKG2-A and CD94/NKG2-C hu-
man C-type lectin-like receptors has been reported (Ta- tides detect a peptide-specific conformation, it was of
interest to know whether the Ly49A and TCR sites onble 1) (ValeÂ s-GoÂ mez et al., 1999). The KD values are
similar to those of the other NK/MHC interactions. H-2Dd were spatially distinct. To address this issue, we
asked whether the binding of H-2Dd to immobilizedIt remained a formal possibility that the engineered
Ly49A EC was interacting with H-2Dd complexes in vitro Ly49A EC, as measured by SPR, could be inhibited by
Immunity
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Figure 5. Staining of Splenocytes with Bio-
tinylated Ly49A EC
(A) Splenocytes (1 3 106) from C57Bl/6 (H-2b),
BALB/c (H-2d), and C3H/HeJ (H-2k) mice were
incubated with biotinylated Ly49A EC and
PE-SA and analyzed by flow cytometry as
described in the Experimental Procedures.
Background staining with PE-SA alone was
identical for all three strains. Staining of
splenocytes from BALB/c (B), C57BL/6 (C),
and b2m2/2 (D) mice was performed as
above, using a lower concentration of the bio-
Ly49A (dark lines). Competition with unla-
beled Ly49A (dotted lines) was carried out
(see the Experimental Procedures).
either scTCR or by Ly49A EC in solution. As shown in the solution phase. (This mAb fails to block the functional
interaction of Ly49A with H-2Dd [Karlhofer et al., 1992].)Figure 6A, addition of scTCR to the binding reaction of
H-2Dd/P18-I10 with Ly49A inhibited in a dose-depen- As shown in Figure 6D, Ly49A EC binds well to the
captured MHC in this orientation and reveals a slowerdent manner. This suggests that the MHC sites for
scTCR binding and for Ly49A binding are at least par- apparent dissociation rate constant (kd 5 0.002 s21 as
compared to the dissociation of the complex in the othertially overlapping.
To confirm the result indicating that the TCR and orientation, kd 5 0.03 s21 [Table 1]), reflecting a higher
apparent affinity. This suggests bivalent binding of theLy49A binding sites on H-2Dd were overlapping, we then
attempted to block the binding of solution phase H-2Dd/ dimeric Ly49A EC to the H-2Dd/P18-I10 array as cap-
tured by the mAb. This binding does not depend on theP18-I10 to immobilized scTCR with Ly49A EC added in
solution. If the sites overlapped, we would expect to presence of the full stalk, as Ly49A NKD-L exhibits the
same behavior (Figure 6E). The observation that H-2Dd/observe competitive inhibition. Surprisingly, addition of
Ly49A EC not only failed to block the binding of H-2Dd/ Ly49A complexes bind to scTCR as shown in 6B raised
the possibility that the formation of ternary H-2Dd/P18-I10 to scTCR, it augmented the binding signal in a
dose-dependent fashion (Figure 6B). Since the binding Ly49A/scTCR complexes could be visualized directly by
the capture of mixtures of these three components bysignal in RU is directly proportional to the mass of mate-
rial bound to the biosensor chip, this augmented signal the anti-a3 domain mAb. Figures 6F and 6G illustrate
that the signal due to binding of H-2Dd/P18-I10 is aug-indicates the simultaneous binding of H-2Dd/P18-I10 to
the immobilized scTCR and to the competitor, Ly49A mented by the addition of scTCR or Ly49A alone. Fur-
thermore, the level of binding is greater when all threeEC. We observed a progressively greater level of binding
as more Ly49A EC was added, suggesting that the components are offered than when any two are pro-
vided. The level of binding of the ternary complex is notLy49A EC cross-linked additional H-2Dd/peptide com-
plexes. The shape of this binding curve is reminiscent simply additive, suggesting that conformational adjust-
ments play a role in its formation.of that observed for the formation of ternary complexes
of MHC II/TCR/superantigen that have recently been The recently determined structure of an H-2Dd/Ly49A
complex (Tormo et al., 1999), along with the known x-rayreported (Andersen et al., 1999). It is difficult to account
for the asymmetry of the competition experimentsÐ structure of a murine TCR/H-2Kb complex (Garcia et al.,
1996), permit the construction of a model that illustratesscTCR blocks binding of H-2Dd to immobilized Ly49A
EC, but Ly49A EC augments binding of H-2Dd to scTCR. the potential for the formation of a ternary complex (Fig-
ure 6H). The TCR/MHC interaction involves the exposedIt is possible that structural constraints imposed on
the covalently immobilized Ly49A EC prevent the ac- surfaces of the center of the a1 and a2 helices and the
bound peptide of the MHC molecule, while the predomi-cessiblity to H-2Dd/TCR complexes. In solution, Ly49A
EC can interact simultaneously with both ligands. nant interaction of Ly49A is with the amino terminal
residues of the a1 helix and the carboxyl terminal resi-To evaluate further the nature of the binding of the
NK receptor to the MHC molecule, we reversed the ori- dues of the a2 helix. As shown in this illustration, the
binding of the TCR and the Ly49A would not be expectedentation of the SPR binding experiment by first capturing
H-2Dd/P18-I10 complexes on the anti-a3 domain mAb, to be mutually exclusive.
Thus, we have demonstrated the in vitro expression34-2-12S, and then introducing Ly49A EC as analyte in
NK Inhibitory Receptor/MHC I Binding Interactions
597
Figure 6. Ly49A EC Can Form Ternary Complexes with scTCR and H-2Dd
CM-5 chips were covalently coupled with either Ly49A EC (A), scTCR (B and C), or mAb 34-2-12S (D±G) as described in the Experimental
Procedures.
(A) Soluble H-2Dd/P18-I10 complexes were offered to the Ly49A EC coupled surface in the presence of scTCR at the indicated concentrations.
(B) H-2Dd/P18-I10 complexes were offered to the scTCR surface in the presence of the indicated concentrations of Ly49A EC.
(C) scTCR competes for H-2Dd/P18-I10 binding to an scTCR surface.
(D and E) H-2Dd/motif was captured on a mAb 34-2-12S surface and then exposed to either Ly49A EC (D) or Ly49A NKD-L (E) as indicated.
Initiation of buffer washout is indicated.
(F and G) Mixtures of Ly49A EC, scTCR, and H-2Dd/P18-I10 were offered to mAb 34-2-12S coupled biosensor surfaces. Mixtures consisted
of 0.08 mM H-2Dd/P18-I10, 1.8 mM scTCR, and either 0.10 mM (F) or 0.32 mM (G) Ly49A EC. Initiation of injection of analyte and of washout
are indicated by arrowheads.
(H) Model of a possible ternary complex of an MHC I molecule with TCR and Ly49A. Superposition of the MHC segment of the structure of
the murine H-2Kb/dEV8/2C TCR complex (pdb designation 2CKB [Garcia et al., 1996]) with the MHC of an H-2Dd/Ly49A complex (Tormo et
al., 1999) was accomplished as described in the Experimental Procedures. Location of the TCR V domains, the MHC I domains, and the
Ly49A NKD are shown.
in a bacterial system of a prototype member of the NKD future experiments. Nevertheless, direct comparison of
the binding of the same preparations of MHC I/peptidefamily, which includes CD94/NKG2, CD69, and NKR-P1.
We have examined the binding, both by AUC and by complexes to both the NK receptor and to a specific
TCR by SPR clearly indicated the difference in peptideSPR, of Ly49A to its major known ligand, the classical
MHC I molecule, H-2Dd. We have established that bind- specificity of the different reactions and showed similar-
ity in the affinity as measured by the same method ating does not require carbohydrate or Ca21, although
we have not yet definitively determined to what degree the same temperature. Although the equilibrium con-
stants are in the 6 to 26 mM range, the NK receptorsglycosylation of the MHC I heavy chain might modulate
this binding. The parameters of binding observed using seem to have a consistently smaller association rate
constant and slower dissociation rate than most TCR/AUC and SPR are significantly different and raise the
question whether there are temperature effects on the MHC interactions that have been studied (Fremont et
al., 1996; Margulies et al., 1996; Davis et al., 1998). Thebinding constant. These questions must be explored in
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amino acids 1 to 280, cloned in pET3a (Zhang et al., 1992), was asmaller ka may reflect a requirement for noncovalent
gift of Dr. K. Parker. The H-2Dd heavy chain construct, encodingdimerization of Ly49A EC prior to binding the MHC or
amino acids 1±277 in pET3a, has been previously described (Li eta need for other conformational adjustments. The lower
al., 1998).
dissociation rate constants that read out in greater t1/2
may suggest a need for a longer dwell time to initiate
Protein Expression, Refolding, and Purification
the inhibitory signals in the NK cell mediated by these Log-phase cultures of E. coli strain BL21(DE3) were induced for
receptors. 3 hr with 0.5 mM isopropyl b-D-thiogalactopyranoside (IPTG) and
The most striking result of these studies is that ternary harvested by centrifugation, and partially purified inclusion bodies
were prepared as described (Kurucz et al., 1993). Inclusion bodiescomplexes of Ly49A, H-2Dd, and a specific TCR can
containing Ly49A protein were denatured and solubilized in 6 Mform. Recent studies suggest that NK receptors, in par-
guanidinium hydrochloride (GuHCl) containing 0.1 mM dithiothreitolticular NK1.1 (Bendelac, 1995), as well as Ly49A itself
(DTT), followed by reoxidation in the presence of glutathione and
(Roland and Cazenave, 1992; MacDonald et al., 1998; dilution into 0.4 M arginine. Ly49A protein was then dialyzed from
Ortaldo et al., 1998), are in some cases expressed on T arginine into Tris-buffered saline (TBS) (25 mM Tris HCl [pH 8.0] and
lymphocytes bearing TCRab. We have shown that the 150 mM NaCl) and was further purified in some cases by binding
to an immunoadsorbent column consisting of the monoclonal anti-Ly49A binding site on H-2Dd is distinct from that of the
body A1 (Nagasawa et al., 1987) coupled to Sepharose CL4B, orTCR binding site, though the distinction is complex as
YE1-32 (Takei et al., 1997) similarly coupled, or by ion-exchangerevealed by the asymmetry of the competition. Several
chromatography (MonoQ, Pharmacia) followed by size exclusion
structures of TCR complexed with MHC/peptide are now chromotography on Superdex 75 HR 10/30. Routinely, the yield of
known (Garboczi et al., 1996; Garcia et al., 1996, 1998; refolded Ly49A EC, Ly49A NKD-L, Ly49A NKD-S is from 5 to 10 mg
Ding et al., 1998; Teng et al., 1998), and these reveal a per liter of bacterial culture.
Bacterial expression and assembly of H-2Dd containing P18-I10common orientation of the MHC/peptide complex on
peptide (RGPGRAFVTI) have been described previously (Li et al.,the bound TCR. Our binding data suggest that the NK
1998). Synthetic peptides were substituted in the refolding protocolreceptor binds at a nearby, but distinct, site and are
to obtain H-2Dd complexed with a variant peptide containing a V to
consistent with both the x-ray structure of an H-2Dd/ N substitution at position 8, or a motif peptide, AGPARAAAL. A
Ly49A complex (Tormo et al., 1999) and experiments similar refolding protocol as for H-2Dd was used to prepare H-2Kb
that functionally discriminate the TCR and Ly49A bind- complexes containing VSV-8 peptide (RGYVYQGL). A three-domain
single chain T cell receptor derived from the H-2Dd/P18-I10-specificing sites on H-2Dd (Chung et al., 1999). Thus, it is possible
T cell hybridoma has been described previously (Plaksin et al., 1997).that NK receptors of the Ly49 family might interact with
the same MHC molecule at the same time as a TCR.
Monoclonal AntibodiesSuch partner sharing by two different receptors, each
MAbs to Ly49A: A1 (BALB/c anti-Ly49ABL/6) (Nagasawa et al., 1987),coupled to a distinct cellular signaling pathway, might
YE1-48 (Takei, 1983), YE1-32 (Takei et al., 1997), and JR9.318 (Ro-offer unique opportunities for the modulation of NK±T
land and Cazenave, 1992), as well as 4D11 (anti-Ly49G2 [Mason et
cell activation. Detailed mutagenic and functional exper- al., 1995]) and SW5E6 (anti-Ly49C [Sentman et al., 1989]) were all
iments, along with further structural studies, should help used as purified protein.
to resolve these issues.
Analytical Ultracentrifugation
Sedimentation equilibrium experiments were performed using aExperimental Procedures
Beckman Optima XL-A with an An60-Ti rotor and absorbance optical
system. Double sector charcoal-filled epon centerpieces were filledLy49A Expression
with 130±180 ml of protein in phosphate-buffered saline (PBS) atA full-length C57BL/6 cDNA clone, pA1.3 (Yokoyama et al., 1989),
concentrations between 0.7 and 8.3 mM and centrifuged to equilib-was used as template for the PCR amplification of four fragments
rium at 48C and at several rotor speeds between 16,000 and 30,000encompassing various regions of the extracellular portion of Ly49A.
rpm. Absorbance distributions were recorded at 230 and 280 nm.(1) The entire extracellular portion (Ly49A EC, residues 67 to 262);
For Ly49A EC and H-2Dd/P18-I10, the molar masses of 23,400 and(2) a truncated region lacking most of the stalk (NKD-L, residues
44,951, the extinction coefficients at 280 nm of 39,420 M21cm21 and109 to 262); (3) a shorter version (NKD-S, residues 149 to 262); and
98,300 M21cm21, and the partial specific volumes of 0.720 and 0.716(4) the Ly49A stalk (residues 67 to 148), using primers that produced
cm3/g at 48C, respectively, were calculated from the amino acida 59 Nhe1 site and a 39BamH1 site, to allow cloning into pET21a
compositions using Sednterp (Laue et al., 1992). The extinction ratio(Novagen) (Studier et al., 1990). Oligonucleotides used for these
e230/e280 was determined from multiwavelength analysis of sedimen-amplifications were: for Ly49A EC, 59 primer, 59-AGCGAGGCTAGCA
tation equilibrium profiles at high rotor speed. Data were analyzedAAATTTTTCAGTATGATCAA and 39 primer, 59-GTCCGGATCCTTAG
by global analysis of several data sets obtained at different loadingGGTATCAGAGAAGATCTGTC; for NKD-L, 59primer, 59-TCTATGGCT
concentrations and different rotor speeds, using MLAB (CivilizedAGCGATCTTCTGGAATCCCTCAAC, and 39 primer, the same as for
Software). Each data set was decomposed into a sum of the wellLy49A EC; for NKD-S, 59 primer, 59-TGCTATGCTAGCAAATGTTATT
known sedimentation equilibrium exponentials for each componentATTTCGTCATGGACAGA and 39 primer same as for Ly49A EC; and
(Svedberg and Pedersen, 1940), linked by the mass action law infor Ly49A stalk, 59 primer, same as for Ly49A EC and 39 primer,
the presence of interactions. The absence of thermodynamic non-59-AATAGGATCCTTATCAACCATAGCAGAACCAGTATACTTTATC.
idealities and pressure effects was assumed. Monomer concentra-This introduces codons encoding M, A, and S immediately amino
tions of each species at a reference radius and a small baselineterminal to those encoding the first residue of the encoded protein
offset were treated as floating parameters local to each data set,(Figure 1A). A termination codon was included preceding the BamHI
whereas association constants were fitted as global parameters.site in the 39 primer. Following 25 cycles of amplification using Taq
polymerase and standard buffer and temperature conditions in an
automated thermocycler, the PCR products were digested with NheI Surface Plasmon Resonance Binding Assays and Data Analysis
Purified proteins were coupled via standard covalent chemistriesand BamHI and cloned into similarly digested pET21a. DNA se-
quencing confirmed the fidelity of the constructs. Full-length mouse to the dextran matrix of a CM-5 sensor chip (BIAcore) as described
previously (Khilko et al., 1993; Corr et al., 1994). All SPR experimentsb2m cloned in pET21d (Novagen) and encoding an additional methi-
onine residue amino terminal to position one I (Shields et al., 1998) were carried out at 258C, using constant flow rate of 10 ml/min.
Binding is measured in resonance units (RU). Both kinetics andwas the gift of Dr. R. Ribaudo. The H-2Kb heavy chain, encoding
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equilibrium data were evaluated on baseline normalized curves us- Hunziker, R., Berzofsky, J.A., Yokoyama, W.M., Mage, M.G., and
Margulies, D.H. (1999). NK and CTL recognition of a single chaining BIAeval 3.0 (BIAcore). Parameters were determined in experi-
H-2Dd molecule: distinct sites of H-2Dd interact with NK and T cellments in which the Ly49A molecules were immobilized, so that no
receptors. J. Immunol. 163, 3699±3708.assumption concerning the valency of Ly49A for MHC was neces-
sary, and Langmuir kinetics analysis could be used. Ciccone, E., Grossi, C.E., and Velardi, A. (1996). Opposing functions
of activatory T-cell receptors and inhibitory NK-cell receptors on
cytotoxic T cells. Immunol. Today 17, 450±453.Flow Cytometry
Splenocytes were incubated with 3 to 7 mg of biotinylated Ly49A Corr, M., Slanetz, A.E., Boyd, L.F., Jelonek, M.T., Khilko, S., al-
EC, prepared as described above, washed in cold PBS, and cross- Ramadi, B.K., Kim, Y.S., Maher, S.E., Bothwell, A.L., and Margulies,
linked and stained with phycoerythrin-streptavidin ([PE-SA], Phar- D.H. (1994). T cell receptor-MHC class I peptide interactions: affinity,
Mingen) on ice. Following additional washing, cells were analyzed kinetics, and specificity. Science 265, 946±949.
on a Becton Dickinson FACScan, gating on live cells by forward Correa, I., and Raulet, D.H. (1995). Binding of diverse peptides to
and side scatter parameters. In competition experiments, spleno- MHC class I molecules inhibits target cell lysis by activated natural
cytes were first incubated for 15 min at 48C with 10 mg unlabeled killer cells. Immunity 2, 61±71.
Ly49A EC prior to adding biotinylated Ly49A EC. Daniels, B.F., Nakamura, M.C., Rosen, S.D., Yokoyama, W.M., and
Seaman, W.E. (1994). Ly-49A, a receptor for H-2Dd, has a functional
Molecular Modeling carbohydrate recognition domain. Immunity 1, 785±792.
The structure of the mouse 2C TCR complexed with H-2Kb/dEV8
Davis, M.M., Boniface, J.J., Reich, Z., Lyons, D., Hampl, J., Arden,
(protein data bank [pdb] accession number 2CKB [Garcia et al., B., and Chien, Y. (1998). Ligand recognition by a b T cell receptors.
1996]) and that of the complex between H-2Dd and Ly49A (Tormo Annu. Rev. Immunol. 16, 523±544.
et al., 1999) were used in a least-squares superposition of the MHC
Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., andI segments using QUANTA 98 (Molecular Simulations). A composite
Wiley, D.C. (1998). Two human T cell receptors bind in a similarmodel consisting of the 2C TCR, H-2Dd/P18-I10 , and the Ly49A
diagonal mode to the HLA-A2/Tax peptide complex using differentdimer is shown.
TCR amino acids. Immunity 8, 403±411.
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